The AP (Artificial Pancreas) system runs an algorithm on a smartphone that communicates with an insulin pump and an implanted glucose sensor.
Research under way at the Icahn School of Medicine at Mount Sinai is revolutionizing the management of type 1 diabetes by using novel technology that serves as an artificial pancreas and automatically enables patients to achieve more stable glucose levels 24 hours a day.
Led by Carol Levy, MD, Associate Professor of Medicine (Endocrinology, Diabetes and Bone Disease), the Icahn School of Medicine is one of nine U.S. and European sites participating in the research, and sharing a $12.7 million grant from the National Institutes of Health. Dr. Levy is one of the study’s lead investigators. Read more
Catherine Roosevelt at the recent Fourteenth Annual Gala of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis.
Catherine Roosevelt is a vibrant 30-year-old woman who is dedicated both to her career as the Advancement Director for a nonprofit organization serving girls living in poverty and to her numerous volunteer commitments. In a typical year, she travels an average of one weekend a month for work or volunteer service and spends a month every summer in Lake Placid, New York, co-directing a summer camp. Combined with a busy social life, her days and evenings can be stressful and tiring, but maintaining an active schedule validates a promise she made to herself six years ago, when she was diagnosed with multiple sclerosis (MS): “I won’t let my disease define me.” Read more
Researchers at Mount Sinai’s Corinne Goldsmith Dickinson Center for Multiple Sclerosis played a key role in developing a potential breakthrough treatment for progressive multiple sclerosis (MS), according to findings that were presented in October 2015 at the meeting of the European Committee for Treatment and Research in MS in Barcelona, Spain. The Center also recently received funding to lead a new international coalition tasked with developing a strategy for diagnosing progressive MS earlier. Both efforts further strengthen Mount Sinai’s reputation as a worldwide leader in MS research. Read more
From left: Reginald Miller, DVM; Dennis S. Charney, MD; and Gary Butts, MD, at the Honorary Deans’ Reception held during Black History Month.
During Black History Month in February, the Icahn School of Medicine at Mount Sinai honored its first black male deans, Gary C. Butts, MD, and Reginald Miller, DVM, for their significant contributions to the institution.
Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, spoke at the Honorary Deans’ Reception that was hosted by Mount Sinai’s Office for Diversity and Inclusion and Black Leaders Advocating for Change and Community, an employee resource group. Read more
Cheyenne Hayward, RN, left, Coronary Care Unit, The Mount Sinai Hospital, checks the blood pressure of visitor Joan Innocent.
More than 775 staff and visitors attended health fairs sponsored by Mount Sinai Heart on Friday, February 5, Go Red for Women Day®, an annual educational event that spotlights the risks of cardiovascular disease. Participants received free screenings for high blood pressure, cholesterol, weight, glucose, and peripheral vascular disease, and learned about nutrition and diet, diabetes, stress management, smoking cessation, and relaxation techniques. Other events included exercise workshops, support group meetings, and educational lectures sponsored by Women’s Heart NY, a comprehensive Mount Sinai Health System heart program.
From left: David L. Reich, MD, President, The Mount Sinai Hospital and Mount Sinai Queens; Marie Winfield, newly elected CAB Vice Chair; John S. Winkleman; Gary Rosenberg, PhD; and David C. Thomas, MD.
Gary Rosenberg, PhD, the Edith J. Baerwald Professor of Preventive Medicine at the Icahn School of Medicine at Mount Sinai, received an award for 30 years of service as Chair of the Mount Sinai Community Advisory Board (CAB) when he retired from that position on Tuesday, February 23.
“Dr. Rosenberg has done a remarkable job chairing the CAB, forging strong connections to the community—particularly the residents of East Harlem—and ensuring that The Mount Sinai Hospital listens and responds to their health care needs and interests,” says John S. Winkleman, Trustee and Chair, Community Relations Committee, Mount Sinai Health System. David C. Thomas, MD, Professor of Medicine (Internal Medicine), Medical Education, and Rehabilitation Medicine, has been elected as the new Chair of the CAB, which was formed in 1979 as a Boards of Trustees committee.
Front row, from left: Althea Reid, Patient Care Associate; Yazmin Navarro, Manager; Terry Altilio, LCSW, Social Work Coordinator; Hinde Nessanbaum, CI, Coordinator; and Milord Baptiste, Lead X-ray Technician. Back row, from left: Cheryl Gilmore-Hall, RN; Carzei O’Neill, CASAC, Counselor; Teisha Horton-Jordan, RN; Susan Somerville, RN; Jinquan Ye, CST, Surgical Technician; and Lakiyah Glivens, Registrar I.
Ten Mount Sinai Beth Israel employees received a 2016 Heart Award, one of the hospital’s most prestigious honors, at a lunch reception on Friday, February 26, held at Podell Auditorium. The award recognizes employees—nominated and selected by their peers—who continuously focus on patient safety, enhancing the patient experience, and making Mount Sinai Beth Israel the hospital of choice for patients, staff, and the community. Mount Sinai Beth Israel President Susan Somerville, RN, congratulated the 2016 awardees at the reception.
From left to right: Arthur Gianelli, President, Mount Sinai St. Luke’s; Jeanine Albu, MD; and Dennis S. Charney, MD
A reception celebrating the opening of the Mount Sinai St. Luke’s Diabetes Center of Excellence, located at 1111 Amsterdam Avenue, was held on Thursday, January 21. The new facility includes spacious outpatient clinical areas, a dedicated space for a weight loss program, and proximity to the headquarters, clinical research unit, and laboratories of the Division of Endocrinology, Diabetes and Bone Disease at Mount Sinai St. Luke’s and Mount Sinai West. The Center will serve a diverse population of patients on Manhattan’s Upper West Side and in Harlem. Read more
From left: Katherine Goldsmith; George J. Gillespie, III; and Joan Noto, President of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis Advisory Board. The Center was founded in 2001 with generous gifts from the late Mount Sinai Trustee Clifford H. Goldsmith and Mr. Gillespie.
Two hundred and fifty donors, patients, faculty, and friends attended the Fourteenth Annual Gala of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis on Thursday, March 3, at The Plaza. Proceeds from the Gala support the Center’s multidisciplinary patient care and innovative research.
Fred D. Lublin, MD, Saunders Family Professor of Neurology at the Icahn School of Medicine at Mount Sinai and the Center’s Director, welcomed the guests and spoke of recent advances in treating multiple sclerosis. Read more
From left: Louella Rudon, Laboratory Manager, Transfusion Medicine; Alina Sanocki; Patricia Galdon, Quality Assurance Manager, Transfusion Medicine; and Vicki LoPachin, MD.
Patient safety is a high priority at The Mount Sinai Hospital, and the Great Catch Program, which teaches staff how to identify and alert leadership to potential safety issues and rewards them for their efforts, is a key component. On Wednesday, February 17, Karen Lott, RN, Department of Perioperative Services, and Alina Sanocki, Lab Tech C, Transfusion Medicine Laboratory, were presented with the Hospital’s first Great Catch Awards. Each received a crystal trophy and a certificate of excellence signed by David L. Reich, MD, President, The Mount Sinai Hospital and Mount Sinai Queens, and Vicki LoPachin, MD, Chief Medical Officer, The Mount Sinai Hospital. Their respective units also received trophies.